EV DYNAMICS (00476.HK) plans to issue in total 3.83 million shares by subscription, with estimated net proceeds of HKD 1.94 million.
NewTimeSpace News: Concord New Energy Group Limited (00182.HK) announced that its 1,000-megawatt (1GW) data center project has completed a large-load interconnection study and received grid connection approval from the Electric Reliability Council of Texas (ERCOT). The facility will be located adjacent to one of the Group’s existing utility-scale solar and battery energy storage projects in Texas.
NewTimeSpace News, Singapore's StarHub announced on April 15 that it has reached an agreement with Ensign Technologies to terminate the previously obtained assignment of rights representing approximately 16.81% equity interest in Ensign InfoSecurity, with a consideration of S$115 million.
NewTimeSpace News, Singapore-based Olam Group announced on April 16 that all necessary regulatory approvals have been obtained for the proposed sale of a 44.58% stake in Olam Agri, with the approval from the last jurisdiction now secured.
Bayzed Health (02609.HK) has shown strong stock performance recently, with cumulative gains exceeding 70% since March. The 2025 annual report shows revenue of approximately RMB 1.12 billion (-5.8% YoY), while the GAAP net loss narrowed to RMB 12.957 million. The adjusted net profit reached RMB 17.9 million, a significant 43.2% increase. The company has established a "full-cycle" oncology service barrier and participated in the release of an expert consensus on cancer rehabilitation. In 2025, net operating cash flow reached a record RMB 222 million. Southbound holdings have risen to 6.92%, signaling that valuation recovery has entered the fast lane.
XIAOMI-W(01810.HK) will spend HKD 177 million to repurchase 5.72 million shares on Apr 15, 2026.
NETEASE MUSIC(09899.HK) will spend HKD 15 million to repurchase 119.95 thousand shares on Apr 15, 2026.
CHINA RAILWAY(00390.HK) will spend CNY 50 million to repurchase 9.42 million shares on Apr 15, 2026.
JIAYUAN SER (01153.HK) plans to issue up to 60.5 million shares by placement, with estimated net proceeds of HKD 14.6 million.
NewTimeSpace News: CSPC Pharmaceutical Group Limited (01093.HK) announced that SYS6051, developed by the Group, has been approved by the National Medical Products Administration (NMPA) to initiate clinical trials in China. The product is a tissue factor (TF)-targeted antibody-drug conjugate (ADC) and was filed as a Class 1 therapeutic biological product. The approved indication is advanced solid tumors.
NewTimeSpace News, Yangzijiang Maritime announced on April 14 that it has signed lease agreements for 13 vessels with a total contract value of US$89.8 million and lease periods ranging from 1 to 8 years.
Driven by its official inclusion in Stock Connect and an earnings recovery, the stock price of Zhida Technology (02650.HK) has rebounded by over 92% since March 24, 2026. The 2025 annual report shows revenue of RMB 716.5 million (+20.7%) and a net loss that narrowed by 30.5% to RMB 164 million. The company is the global sales leader in home charging piles (with a 13.6% market share in China) and has a cumulative global shipment of over 1.3 million units. While overseas revenue surged 70.5% to account for 17.1% of total revenue, the company has not been profitable in its 15-year history and faces a lack of self-funding capacity, with net operating cash outflow widening to RMB 202 million in 2025.
The stock price of 160 Health (02656.HK) fell rapidly after breaking HKD 150 in March 2026, closing at HKD 44.42 on April 13, with over HKD 35 billion in market value evaporating from its peak. The company recently released its 2025 annual report, showing revenue of HKD 652 million (+5.02%) and an adjusted net income of approximately HKD 4.061 million, successfully turning a profit. Relying on its "Platform + AI Agent + Operations" model, it achieved "160 AI Hospital" cooperation with 82 public hospitals in 2025. However, facing the intensive layout of tech giants like Baidu (DoctorClaw) and Alibaba Health (Hydrogen Ion) in the Medical AI Agent track, the company faces severe challenges.
NewTimeSpace News, April 14,ES Group announced that it has been granted a waiver by the Singapore Exchange Regulation from compliance with Rule 1014(2) of the Catalist Rules, which requires Shareholders' approval for the proposed disposal of its vessel, ES Jewel.
NewTimeSpace News, April 14,VCPlus announced that it has entered into a subscription agreement with subscriber Ms. Zhao YiQing to issue 350 million new shares at an issue price of S$0.0034 per share, with a total cash consideration of approximately S$1.19 million.
NewTimeSpace News, April 15,F&N announced that it intends to participate as a cornerstone investor in the proposed equity capital raising of New Zealand Exchange-listed Comvita through its wholly-owned subsidiary, F&N Ventures Pte Ltd. F&N's expected aggregate investment commitment is up to approximately NZ$20.1 million (S$15 million), with a targeted shareholding of 19.99% upon completion.
